Share

PRESS RELEASE: Cancer survivors need better support to get jobs and access loans, say researchers

Amsterdam, March 1, 2018 – More and more people are surviving cancer. Yet support for people who survive cancer and the research that underpins their care is insufficient, particularly when it comes to non-medical issues. A new special issue of the Journal of Cancer Policy, which will be published in March following the 3rd EORTC Cancer Survivorship Summit to be held in Brussels on March 1st and 2nd, shines a light on the issues and calls for more long-term research, better cross-analysis of different cancer types and better support for those who survive the disease.

Read more

Back to news list

Related News

  • EORTC: Advancing research and treatment for rare cancers

  • EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration

  • Appointment of Malte Peters as EORTC Strategic Alliance Officer

  • Unique series of workshops in partnership with the European Medicines Agency (EMA)

  • EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)

  • Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023

  • EORTC Quality of Life measures integrated in CDISC

  • EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma

  • Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia

  • New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023